The Brand Names for Tirzepatide and What They Mean in the UK

Where the name Mounjaro comes from, and what NICE and the MHRA say about it

When Eli Lilly sought UK marketing authorisation for tirzepatide as a weight-management medicine, they chose Mounjaro as the brand name. The MHRA granted that authorisation, and NICE subsequently evaluated the same product under its proper generic name (tirzepatide) producing technology appraisal TA1026, published in December 2024. In practice, when a prescriber writes "tirzepatide" or "Mounjaro" on a UK prescription, they mean the same medicine. The distinction matters mainly in conversation: patients searching online often encounter both names and, increasingly, the US brand name Zepbound too, which adds confusion.

The BNF lists the medicine under its generic name (tirzepatide) with Mounjaro noted as the brand. That is standard practice across the NHS. If your GP or an online prescriber mentions tirzepatide, they are talking about what arrives as a Mounjaro KwikPen. The pen itself, a pre-filled injector delivering four weekly doses, carries the Mounjaro name on the packaging you receive.

Mounjaro holds two separate UK licences: one for weight management in adults with a BMI of 30 or above (or 27 or above with a weight-related condition), and one for type 2 diabetes. The weight-management indication was the later addition, following the SURMOUNT trial programme, and is what most people asking about the tirzepatide brand name and how it came to be approved for weight loss are interested in.

Zepbound: why a name that appears everywhere online is irrelevant to UK patients

Zepbound is tirzepatide with a different label, approved by the FDA for weight management in the United States. It does not hold a UK or European licence, and no UK pharmacy (regulated or otherwise) can legally supply it. The reason it crops up in UK searches is straightforward: American health media covers it extensively, and that content reaches British readers. It is also worth knowing that some sellers operating without proper oversight have been known to use unfamiliar brand names to obscure the origin of what they are selling.

The MHRA has warned publicly about counterfeit and illegally traded weight-loss medicines, including fake pens seized in large numbers across the UK. If you encounter a seller offering tirzepatide under a name other than Mounjaro, or claiming to supply Zepbound to a UK address, that is a serious red flag. You can verify any online pharmacy's legitimacy through the GPhC's public register of pharmacies. Legitimate supply means Mounjaro, from a GPhC-registered pharmacy, on a valid UK prescription.

For a fuller picture of how tirzepatide's various drug names are used in clinical and regulatory contexts, the key distinction is always the same: generic name for clinical and regulatory use, brand name on the box.

What the SURMOUNT evidence tells us, and how it applies to the licensed product

The evidence base for Mounjaro's weight-management licence came primarily from the SURMOUNT clinical programme. SURMOUNT-1, published in the New England Journal of Medicine, enrolled 2,539 adults with obesity and showed average body-weight reductions of around 20–21% at the 15 mg dose over 72 weeks. That trial used tirzepatide, the same molecule dispensed as Mounjaro in UK pharmacies today. The brand name changed between regions; the clinical data did not.

This matters when reading coverage of results online. A headline citing Mounjaro trial data and one citing tirzepatide trial data are drawing on the same pool of evidence. If you want to understand the full range of tirzepatide names you might come across, including Zepbound and the generic, Zepbound's US approval rested on the same SURMOUNT programme, which is why some sources describe all three as interchangeable. In a scientific sense they are; in a legal and supply-chain sense, only Mounjaro is relevant to anyone in the UK.

Thinking about whether this kind of treatment might suit your situation? Our prescribers review consultations the same day, and you can read more about tirzepatide as a weight-management medicine before you take that step. For context on what private treatment typically costs, the weight-loss treatment overview sets out what to expect.

Generic tirzepatide: is there a non-branded version available in the UK?

A question our prescribers hear fairly regularly is whether a cheaper, unbranded version of tirzepatide exists, especially as the cost of Mounjaro has risen since Eli Lilly adjusted its UK list price in autumn 2025. The short answer is no. Tirzepatide is still under patent protection, which means Mounjaro is the only legitimate form of the medicine available in the UK. There is no licensed generic, no biosimilar, and no approved alternative formulation.

Anything sold as "generic tirzepatide" or under a name that isn't Mounjaro should be treated with caution, and our page covering what sits behind the tirzepatide brand explains why the patent situation makes any alternative version impossible to source legitimately in the UK. The MHRA's enforcement work has uncovered counterfeit tirzepatide pens (including the first illicit UK manufacturing site, raided in Northampton in October 2025) confirming that fake products are a real and present risk, not a theoretical one.

If you want to understand more about how Mounjaro works as a licensed UK medicine, or are ready to see whether you meet the clinical criteria, a consultation with our prescribing team is the right starting point. We're a GPhC-registered pharmacy (registration number 9012878, verifiable at pharmacyregulation.org) and every consultation is reviewed by a named prescriber, not automated software.

If you're ready to take that step, start your free consultation and a prescriber will review your answers the same day.